Idea Exchange Meeting with Helen Evans (GAVI Alliance CEO), Suzuki Shigeharu (Chairman of Daiwa Securities Group), and HGPI
date : 6/3/2011
Although Febuarys Global Health Forum had a very broad theme, it was agreed that Japan will continue to confront global health issues using public funds and market mechanisms that use private funds. It was widely agreed that the significance of private funding needs to be expanded.
Since 2008, a total of 15 billion dollars in vaccine bonds was purchased by Japanese citizens, which supported many GAVI alliance activities. Arranged by Daiwa, vaccine bonds are issued by The International Finance Facility for Immunization Company (IFFIm). IFFIm raises funds in the international capital markets that are used by the GAVI Alliance to save children’s lives and protect people’s health by increasing access to immunization in developing countries.
Evans commenced the meeting by expression her gratitude to the Japanese for their cooperation with The GAVI Alliance. Japanese citizens have proven, and can continue to prove, the importance of their participation in innovative financial mechanisms like the vaccine bonds. In the future, GAVI Alliance, alongside Japanese businesses and think tanks, hopes to further validate the importance of strong cooperation.
Exhibition date:2011-06-03
Top Research & Recommendations Posts
- [Research Report] Perceptions, Knowledge, Actions and Perspectives of Healthcare Organizations in Japan in Relation to Climate Change and Health: A Cross-Sectional Study (November 13, 2025)
- [Research Report] The 2025 Public Opinion Survey on Healthcare in Japan (March 17, 2025)
- [Policy Recommendations] Mental Health Project: Recommendations on Three Issues in the Area of Mental Health (July 4, 2025)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Announcement] HGPI Endorses the “Belém Health Action Plan” (November 14, 2025)
- [Policy Recommendations] Recommendations on Strategic Investments in Policies for Brain Health to Revitalize Japan: Hopes for the New Administration (December 1, 2025)
- [Policy Recommendations] Reshaping Japan’s Immunization Policy for Life Course Coverage and Vaccine Equity: Challenges and Prospects for an Era of Prevention and Health Promotion (April 25, 2025)
- [Announcement] HGPI Joins Global Green and Healthy Hospitals (August 1, 2023)
- [Research Report] Survey of Japanese Nursing Professionals Regarding Climate Change and Health (Final Version) (November 14, 2024)
Featured Posts
-
2025-12-09
[Event Report] Special Seminar “Rising to New Challenges in Health Sciences for Future Society: Novel Developments in the Field of Epilepsy in Japan and Globally” Belgium Pavilion Special Seminar, World Expo 2025 Osaka, Kansai (September 18, 2025)
-
2025-12-11
[Event Report] Core Components of Universal Health Coverage (UHC): Achieving “Healthcare Without Financial Hardship” in Asia-Pacific and Japan (December 5, 2025)
-
2025-12-12
[Registration Open] Meaningful Involvement Promotion Project Urgent Symposium “The New Takaichi Administration and Central Social Insurance Medical Council Reform – Ensuring Patients’ Voices are Heard” (January 22, 2026)
-
2025-12-12
[Registration Open] (Webinar) The 140th HGPI Seminar “Early Detection to Reduce COPD Disease Burden: Connecting Clinical Frontiers with Health Policy” (January 27, 2026)
-
2025-12-16
[Discussion Points] Policy Dialogue “Considering Comprehensive Genomic Profiling from the Perspective of Patient Access: Utilizing the Medical Service Fee Reimbursement System and the Mixed Medical Services Program to Meet the Needs of Today” (November 28, 2025)



